目の健康サプリメントの世界市場：市場規模・シェア・動向分析 (原料の種類別・適応症別・剤形別・地域別)、セグメント別予測 (2025年～2030年)

目の健康サプリメント市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の目の健康サプリメントの市場規模は2030年までに29億4,000万米ドルに達すると予測され、2025年から2030年にかけてCAGR 7.1％で拡大すると予測されています。

高齢者人口の増加、ブルーライトへの暴露の増加、黄斑変性症、屈折異常、白内障、炎症、糖尿病性網膜症、角膜混濁、トラコーマ、ドライアイ症候群などの様々な視力障害の有病率の増加が市場を牽引する主な要因です。加えて、眼科医療サービスの質のばらつき、労働力不足、屋外で過ごす時間の減少につながるライフスタイルの変化、栄養習慣の乱れや食品の質の低下、目の健康に関する意識の高まりなどが、市場の成長をさらに後押ししています。

さらに、デジタル機器の普及がデジタル眼精疲労の増加に寄与しています。スクリーンを長時間使用するとブルーライトにさらされ、不快感を感じたり、視力に長期的な影響を及ぼす可能性があります。このため、目の健康の重要性に対する意識が高まり、有害なブルーライトを除去し、網膜の健康をサポートする可能性があることで知られるルテインやゼアキサンチンなどの成分を含むサプリメントを求める消費者が増えています。

eコマース・プラットフォームを含む様々な流通チャネルを通じて幅広い種類の目の健康サプリメントが入手可能になったことで、これらの製品は世界的に入手しやすくなりました。この入手しやすさが効果的なマーケティング戦略と相まって、目の健康サプリメントに対する消費者の認識と採用率の向上に寄与しています。さらに、ヘルスケア支出の増加、特に予防医療への支出が、目の健康維持と視力障害の予防に役立つ製品への消費者の投資意欲を高め、目の健康サプリメントの需要を牽引しています。

目の健康サプリメント市場：分析概要

• ルテイン・ゼアキサンチン成分は、2024年に33.4%の最大収益シェアを占め、成分タイプセグメントを支配しています。
• α-リポ酸（ALA）は、白内障や黄斑変性症などの加齢に関連した眼疾患との闘いにおけるその効率性に起因して、予測期間中にCAGR 8.3％で成長すると予想されています。
• 加齢黄斑変性（AMD）は市場をリードし、2024年には32.2%の最大の売上シェアを占めました。
• この炎症は、汚染、スクリーン使用時間の増加、高齢化により、予測期間中に10.7％の有利なCAGRで成長すると予想されています。
• 錠剤セグメントは、世界の目の健康サプリメント市場を独占し、2024年に最大の収益シェアを占めました。カプセルは、2025年から2030年にかけてCAGR 6.9％で成長する見込みです。
• 北米は、2024年の世界の目の健康サプリメント市場で最大の収益シェアを占めました。これは主に、慢性眼疾患、特に加齢黄斑変性症（AMD）、糖尿病性網膜症、緑内障、ドライアイ症候群の発生が増加していることによります。
• 2024年5月、ヘルシーセルは視力と網膜の健康をサポートする超吸収性ジェル状サプリメント「アイヘルス」を発売しました。ルテイン、ゼアキサンチン、アスタキサンチン、リコピン、ビタミンA、E、亜鉛などの栄養素を配合し、視力を促進し、酸化ストレスから保護することを目的としています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 世界の目の健康サプリメント市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 目の健康サプリメント市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 世界の目の健康サプリメント市場：原料の種類別のビジネス分析

• 原料の種類別のダッシュボード
• 目の健康サプリメント市場：原料の種類別の変動分析
• 世界の目の健康サプリメント市場：市場規模と動向分析、原料の種類別（2018～2030年）
• ルテインとゼアキサンチン
• 抗酸化物質
• オメガ3脂肪酸
• フラボノイド
• アルファリポ酸
• コエンザイムQ10
• アスタキサンチン
• その他

第5章 世界の目の健康サプリメント市場：適応症別のビジネス分析

• 適応症別のダッシュボード
• 目の健康サプリメント市場：適応症別の変動分析
• 世界の目の健康サプリメント市場：市場規模と動向分析、適応症別（2018～2030年）
• 加齢黄斑変性症（AMD）
• ドライアイ症候群
• 炎症
• 白内障
• その他

第6章 世界の目の健康サプリメント市場：剤形別のビジネス分析

• 剤形別のダッシュボード
• 目の健康サプリメント市場：剤形別の変動分析
• 世界の目の健康サプリメント市場：市場規模と動向分析、剤形別（2018～2030年）
• 錠剤
• カプセル
• 液体
• ソフトジェル
• 粉末
• その他

第7章 世界の目の健康サプリメント市場：地域別の推定・動向分析

• 地域別の市場ダッシュボード
• 地域別の市場シェア分析（2024年・2030年）
• 世界の目の健康サプリメント市場：主なポイント、地域別
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 最近の動向と影響分析：主要市場参入企業別
• 企業/競合の分類
• ベンダー情勢
  • 主要企業のヒートマップ分析（2024年）
• 企業プロファイル
  • The Nature's Bounty Co.
  • Vitabiotics Ltd.
  • Pfizer Inc
  • Amway International
  • Bausch &Lomb
  • Nutrivein
  • ZeaVision LLC
  • Kemin Industries, Inc.
  • EyeScience
  • Nutrachamps

List of Tables

• Table 1 List Of Abbreviations
• Table 2 Global Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 3 Global Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 4 Global Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 5 Global Eye Health Supplements Market, By Region, 2018 - 2030 (USD Million)
• Table 6 North America Eye Health Supplements Market, By Country, 2018 - 2030 (USD Million)
• Table 7 North America Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 8 North America Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 9 North America Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 10 U.S. Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 11 U.S. Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 12 U.S. Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 13 Canada Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 14 Canada Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 15 Canada Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 16 Mexico Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 17 Mexico Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 18 Mexico Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 19 Europe Eye Health Supplements Market, By Country, 2018 - 2030 (USD Million)
• Table 20 Europe Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 21 Europe Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 22 Europe Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 23 Germany Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 24 Germany Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 25 Germany Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 26 UK Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 27 UK Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 28 UK Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 29 France Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 30 France Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 31 France Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 32 Italy Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 33 Italy Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 34 Italy Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 35 Spain Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 36 Spain Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 37 Spain Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 38 Denmark Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 39 Denmark Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 40 Denmark Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 41 Sweden Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 42 Sweden Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 43 Sweden Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 44 Norway Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 45 Norway Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 46 Norway Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Eye Health Supplements Market, By Country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 51 China Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 52 China Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 53 China Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 54 Japan Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 55 Japan Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 56 Japan Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 57 India Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 58 India Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 59 India Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 60 South Korea Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 61 South Korea Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 62 South Korea Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 63 Australia Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 64 Australia Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 65 Australia Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 66 Thailand Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 67 Thailand Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 68 Thailand Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 69 Latin America Eye Health Supplements Market, By Country, 2018 - 2030 (USD Million)
• Table 70 Latin America Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 71 Latin America Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 72 Latin America Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 73 Brazil Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 74 Brazil Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 75 Argentina Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 76 Argentina Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 77 Argentina Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 78 MEA Eye Health Supplements Market, By Region, 2018 - 2030 (USD Million)
• Table 79 MEA Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 80 MEA Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 81 MEA Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 82 South Africa Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 83 South Africa Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 84 South Africa Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 88 UAE Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 89 UAE Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 90 UAE Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)
• Table 91 Kuwait Eye Health Supplements Market, By Ingredient Type, 2018 - 2030 (USD Million)
• Table 92 Kuwait Eye Health Supplements Market, By Indication, 2018 - 2030 (USD Million)
• Table 93 Eye Health Supplements Market, By Formulation, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Data Triangulation Techniques
• Fig. 3 Primary Research Pattern
• Fig. 4 Primary Interviews
• Fig. 5 Market Research Approaches
• Fig. 6 Value-Chain-Based Sizing & Forecasting
• Fig. 7 QFD Modeling for Market Share Assessment
• Fig. 8 Market Formulation & Validation
• Fig. 9 Eye Health Supplements Market: Market Outlook
• Fig. 10 Eye Health Supplements Competitive Insights
• Fig. 11 Parent Market Outlook
• Fig. 12 Related/Ancillary Market Outlook
• Fig. 13 Penetration and Growth Prospect Mapping
• Fig. 14 Industry Value Chain Analysis
• Fig. 15 Eye Health Supplements Market Driver Impact
• Fig. 16 Eye Health Supplements Market Restraint Impact
• Fig. 17 Eye Health Supplements Market Strategic Initiatives Analysis
• Fig. 18 Eye Health Supplements Market: Ingredient Type Movement Analysis
• Fig. 19 Eye Health Supplements Market: Ingredient Type Outlook and Key Takeaways
• Fig. 20 Lutein and Zeaxanthin Market Estimates and Forecast, 2018 - 2030
• Fig. 21 Antioxidants Market Estimates and Forecast, 2018 - 2030
• Fig. 22 Omega-3 Fatty acids Market Estimates and Forecast, 2018 - 2030
• Fig. 23 Flavonoids Market Estimates and Forecast, 2018 - 2030
• Fig. 24 Alpha-Lipoic Acid Market Estimates and Forecast, 2018 - 2030
• Fig. 25 Coenzyme Q10 Market Estimates and Forecast, 2018 - 2030
• Fig. 26 Astaxanthin Market Estimates and Forecast, 2018 - 2030
• Fig. 27 Others Market Estimates and Forecast, 2018 - 2030
• Fig. 28 Eye Health Supplements Market: Indication Movement Analysis
• Fig. 29 Eye Health Supplements Market: Indication Outlook and Key Takeaways
• Fig. 30 Age-related Macular Degeneration (AMD) Market Estimates and Forecasts, 2018 - 2030
• Fig. 31 Dry Eye Syndrome Market Estimates and Forecasts, 2018 - 2030
• Fig. 32 Inflammation Market Estimates and Forecasts, 2018 - 2030
• Fig. 33 Cataract Market Estimates and Forecasts, 2018 - 2030
• Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030
• Fig. 35 Eye Health Supplements Market: Formulation Movement Analysis
• Fig. 36 Eye Health Supplements Market: Formulation Outlook and Key Takeaways
• Fig. 37 Tablets Market Estimates and Forecasts, 2018 - 2030
• Fig. 38 Capsules Market Estimates and Forecasts, 2018 - 2030
• Fig. 39 Liquid Market Estimates and Forecasts, 2018 - 2030
• Fig. 40 Softgels Market Estimates and Forecasts, 2018 - 2030
• Fig. 41 Powder Market Estimates and Forecasts, 2018 - 2030
• Fig. 42 Others Market Estimates and Forecasts, 2018 - 2030
• Fig. 43 Global Eye Health Supplements Market: Regional Movement Analysis
• Fig. 44 Global Eye Health Supplements Market: Regional Outlook and Key Takeaways
• Fig. 45 North America Market Estimates and Forecasts, 2018 - 2030
• Fig. 46 U.S. Market Estimates and Forecasts, 2018 - 2030
• Fig. 47 Canada Market Estimates and Forecasts, 2018 - 2030
• Fig. 48 Mexico Market Estimates and Forecasts, 2018 - 2030
• Fig. 49 Europe Market Estimates and Forecasts, 2018 - 2030
• Fig. 50 UK Market Estimates and Forecasts, 2018 - 2030
• Fig. 51 Germany Market Estimates and Forecasts, 2018 - 2030
• Fig. 52 France Market Estimates and Forecasts, 2018 - 2030
• Fig. 53 Italy Market Estimates and Forecasts, 2018 - 2030
• Fig. 54 Spain Market Estimates and Forecasts, 2018 - 2030
• Fig. 55 Denmark Market Estimates and Forecasts, 2018 - 2030
• Fig. 56 Sweden Market Estimates and Forecasts, 2018 - 2030
• Fig. 57 Norway Market Estimates and Forecasts, 2018 - 2030
• Fig. 58 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
• Fig. 59 China Market Estimates and Forecasts, 2018 - 2030
• Fig. 60 Japan Market Estimates and Forecasts, 2018 - 2030
• Fig. 61 India Market Estimates and Forecasts, 2018 - 2030
• Fig. 62 Thailand Market Estimates and Forecasts, 2018 - 2030
• Fig. 63 South Korea Market Estimates and Forecasts, 2018 - 2030
• Fig. 64 Australia Market Estimates and Forecasts, 2018 - 2030
• Fig. 65 Latin America Market Estimates and Forecasts, 2018 - 2030
• Fig. 66 Brazil Market Estimates and Forecasts, 2018 - 2030
• Fig. 67 Argentina Market Estimates and Forecasts, 2018 - 2030
• Fig. 68 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 69 South Africa Market Estimates and Forecasts, 2018 - 2030
• Fig. 70 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
• Fig. 71 UAE Market Estimates and Forecasts, 2018 - 2030
• Fig. 72 Kuwait Market Estimates and Forecasts, 2018 - 2030

Eye Health Supplements Market Growth & Trends:

The global eye health supplements market size is anticipated to reach USD 2.94 billion by 2030 and is anticipated to expand at a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising elderly population, growing exposure to blue light, and increasing prevalence of various vision disorders such as macular degeneration, refractive errors, cataract, inflammation, diabetic retinopathy, corneal opacity, trachoma, and dry eye syndrome are the major factors driving the market. In addition, uneven quality of eye care services, workforce shortages, lifestyle changes leading to less time spent outdoors, poor nutritional habits and dropping food quality, and increasing awareness regarding eye health is further boosting the market growth.

In addition, the widespread use of digital devices has contributed to a rise in digital eye strain. Extended screen time exposes individuals to blue light, which can lead to discomfort and potential long-term effects on vision. This has heightened awareness about the importance of eye health, prompting consumers to seek supplements containing ingredients like lutein and zeaxanthin, known for their potential to filter injurious blue light and support retinal health.

The availability of a wide range of eye health supplements through various distribution channels, including e-commerce platforms, has made these products more accessible globally. This accessibility, combined with effective marketing strategies, has contributed to increased consumer awareness and adoption of eye health supplements. Additionally, rising healthcare expenditures, particularly on preventive care, have driven the demand for eye health supplements, as consumers are willing to invest in products that help maintain their eye health and prevent vision problems.

Eye Health Supplements Market Report Highlights:

• Lutein & zeaxanthin ingredients dominated the ingredient type segment with the largest revenue share of 33.4% in 2024, driven by the growing occurrence of eye disorders, mainly AMD.
• Alpha-Lipoic Acid (ALA) is expected to grow at a CAGR of 8.3% over the forecast period, attributed to its efficiency in fighting age-related eye conditions, such as cataracts and macular degeneration.
• Age-related Macular Degeneration (AMD) led the market and held the largest revenue share of 32.2% in 2024, as it impacts the macula, the central region of the retina responsible for sharp, central vision.
• The inflammation is expected to grow at a lucrative CAGR of 10.7% over the forecast period, owing to increased pollution, screen time, and aging.
• The tablets segment dominated the global eye health supplements market and accounted for the largest revenue share in 2024. Capsules are expected to grow at a CAGR of 6.9% from 2025 to 2030.
• NorthAmerica dominated the global eye health supplements market with the largest revenue share in 2024. This was primarily driven by the rising occurrence of chronic eye conditions, specifically age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and dry eye syndrome.
• In May 2024, HealthyCell launched Eye Health, an ultra-absorbable gel supplement designed to support vision and retinal health. Formulated with nutrients like lutein, zeaxanthin, astaxanthin, lycopene, vitamins A and E, and zinc, it aims to promote visual acuity and protect against oxidative stress.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Ingredient Type
  • 1.2.2. Indication
  • 1.2.3. Formulation
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Ingredient Type Outlook
  • 2.2.2. Indication Outlook
  • 2.2.3. Formulation Outlook
  • 2.2.4. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Eye Health Supplements Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Global Eye Health Supplements Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Global Eye Health Supplements Market: Ingredient Type Business Analysis

• 4.1. Ingredient Type Segment Dashboard
• 4.2. Eye Health Supplements Market: Ingredient Type Movement Analysis
• 4.3. Global Eye Health Supplements Market Size & Trend Analysis, By Ingredient Type, 2018 to 2030 (USD Million)
• 4.4. Lutein and Zeaxanthin
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Antioxidants
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.6. Omega-3 Fatty acids
  • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.7. Flavonoids
  • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.8. Alpha-Lipoic Acid
  • 4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.9. Coenzyme Q10
  • 4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.10. Astaxanthin
  • 4.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.11. Others
  • 4.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Eye Health Supplements Market: Indication Business Analysis

• 5.1. Indication Segment Dashboard
• 5.2. Eye Health Supplements Market: Indication Movement Analysis
• 5.3. Global Eye Health Supplements Market Size & Trend Analysis, By Indication, 2018 to 2030 (USD Million)
• 5.4. Age-related Macular Degeneration (AMD)
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Dry Eye Syndrome
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Inflammation
  • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.7. Cataract
  • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Eye Health Supplements Market: Formulation Business Analysis

• 6.1. Formulation Segment Dashboard
• 6.2. Eye Health Supplements Market: Formulation Movement Analysis
• 6.3. Global Eye Health Supplements Market Size & Trend Analysis, By Formulation, 2018 to 2030 (USD Million)
• 6.4. Tablets
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Capsules
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.6. Liquid
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.7. Softgels
  • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.8. Powder
  • 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Eye Health Supplements Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market Share Analysis, 2024 & 2030
• 7.3. Global Eye Health Supplements Market by Regional: Key Takeaways
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key Country Dynamics
    • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.1.3. Competitive Scenario
    • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Germany
    • 7.5.1.1. Key Country Dynamics
    • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.1.3. Competitive Scenario
    • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Denmark
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Norway
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.8.3. Competitive Scenario
    • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key Country Dynamics
    • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.1.3. Competitive Scenario
    • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Thailand
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. South Africa
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.3.3. Competitive Scenario
    • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.4.3. Competitive Scenario
    • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key Company Heat Map Analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. The Nature's Bounty Co.
    • 8.4.1.1. Company Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Vitabiotics Ltd.
    • 8.4.2.1. Company Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Pfizer Inc
    • 8.4.3.1. Company Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Amway International
    • 8.4.4.1. Company Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Bausch & Lomb
    • 8.4.5.1. Company Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Nutrivein
    • 8.4.6.1. Company Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. ZeaVision LLC
    • 8.4.7.1. Company Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Kemin Industries, Inc.
    • 8.4.8.1. Company Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. EyeScience
    • 8.4.9.1. Company Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Nutrachamps
    • 8.4.10.1. Company Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives